Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised ph... by de Boer, Stephanie M, MD, Powell, Melanie E, MD, Mileshkin, Linda, MD, Katsaros, Dionyssios, Prof, Bessette, Paul, Prof, Haie-Meder, Christine, MD, Ottevanger, Petronella B, MD, Ledermann, Jonathan A, Prof, Khaw, Pearly, MD, D'Amico, Romerai, MD, Fyles, Anthony, Prof, Baron, Marie-Helene, MD, Jürgenliemk-Schulz, Ina M, PhD, Kitchener, Henry C, Prof, Nijman, Hans W, Prof, Wilson, Godfrey, MD, Brooks, Susan, MD, Gribaudo, Sergio, MD, Provencher, Diane, Prof, Hanzen, Chantal, MD, Kruitwagen, Roy F, Prof, Smit, Vincent T H B M, Prof, Singh, Naveena, MD, Do, Viet, MD, Lissoni, Andrea, MD, Nout, Remi A, MD, Feeney, Amanda, MSc, Verhoeven-Adema, Karen W, PhD, Putter, Hein, Prof, Creutzberg, Carien L, Prof

Get full text

Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised,... by de Boer, Stephanie M, Powell, Melanie E, Mileshkin, Linda, Katsaros, Dionyssios, Bessette, Paul, Haie-Meder, Christine, Ottevanger, Petronella B, Ledermann, Jonathan A, Khaw, Pearly, Colombo, Alessandro, Fyles, Anthony, Baron, Marie-Helene, Jürgenliemk-Schulz, Ina M, Kitchener, Henry C, Nijman, Hans W, Wilson, Godfrey, Brooks, Susan, Carinelli, Silvestro, Provencher, Diane, Hanzen, Chantal, Lutgens, Ludy C H W, Smit, Vincent T H B M, Singh, Naveena, Do, Viet, D'Amico, Romerai, Nout, Remi A, Feeney, Amanda, Verhoeven-Adema, Karen W, Putter, Hein, Creutzberg, Carien L, McCormack, Mary, Whitmarsh, Karen, Allerton, Rozenn, Gregory, Deborah, Symonds, Paul, Hoskin, Peter J., Adusumalli, Madhavi, Anand, Anjana, Wade, Robert, Stewart, Alexandra, Taylor, Wendy, Kruitwagen, Roy F.P.M., Hollema, Harry, Pras, Elizabeth, Snyers, An, Stalpers, Lukas, Jobsen, Jan J., Slot, Annerie, Mens, Jan-Willem M., Stam, Tanja C., Van Triest, Baukelien, Van der Steen - Banasik, Elzbieta M., De Winter, Karin A.J., Quinn, Michael A., Kolodziej, Ilka, Pyman, Jan, Johnson, Carol, Capp, Anne, Fossati, Roldano, Gribaudo, Sergio, Lissoni, Andrea A., Ferrero, Annamaria, Artioli, Grazia, Davidson, Cathy, McLachlin, C. Meg, Ghatage, Prafull, Rittenberg, Paula V.C., Souhami, Luis, Thomas, Gillian, Duvillard, Pierre, Berton-Rigaud, Dominique, Tubiana-Mathieu, Nicole

Get full text

Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS)... by Forbes, John F, Prof, Sestak, Ivana, PhD, Howell, Anthony, Prof, Bonanni, Bernardo, MD, Bundred, Nigel, Prof, Levy, Christelle, MD, von Minckwitz, Gunter, Prof, Eiermann, Wolfgang, MD, Neven, Patrick, Prof, Stierer, Michael, Prof, Holcombe, Chris, MD, Coleman, Robert E, Prof, Jones, Louise, Prof, Ellis, Ian, Prof, Cuzick, Jack, Prof

Get full text

6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial by Kerbrat, Pierre, Fumoleau, Pierre, Jacquin, Jean-Philippe, Abadie-Lacourtoisie, Sophie, Cany, Laurent, Khayat, David, Paget-Bailly, Sophie, Demarchi, F, N'Guyen, T, Stein, U, Villanueva, C, Guimont, I, Lévy, E, Delbaldo, C, Pouessel, D, Fournel-Fédérico, C, Freyer, G, Tartas, S, Bons, F, Cuvier, C, Hajjaji, N, Capitain, O, Maillart, P, Bonnefoi, H, Durand, M, Madranges, N, Mauriac, L, Durando, X, Durieux, A, Piperno-Neumann, S, Tresca, P, Ferrant, E, Mayer, F, Vanneuville, AC, Servent, V, Guastalla, JP, Biron, P, Dupuy-Brousseau, L, Lancry, L, Trédan, O, Extra, JM, Berton-Rigaud, D, Ferrero, JM, Largillier, R, Gedoin, D, Laguerre, B, Lefeuvre, C, Vauléon, E, Tennevet, I, Mefti-Lacheraf, F, Dalenc, F, André, F, Domont, J, Ezenfis, J, Provençal, J, Bellaiche-Miccio, C, Boutan-Laroze, G, Arsène, O, Merad-Boudia, Z, Orfeuvre, H, Lamy, R, Sarda, C, Salles, B, Cauvin, I, Mangold, M, Bourcier, A, Geay, JF, ElAmarti, R, Combe, M, Dauba, J, Denizon, N, Clavreul, G, Goubely, Y, Delecroix, V, Ligeza-Poisson, V, Leyronnas, C, Teissier, E, Bernard, O, Pottier-Kyndt, V, Drony, S, Moriceau, M, Besson, D, Achille, E, Moran-Ribon, A, Moullet, I, Couderc, B, Burki, F, Schaeffer, F, Montcuquet, P, Baumont, GA, Gréget, S, Ratoanina, JL, Bonichon-Lamichhane, M, Cartron, G, Dupuis, O, Ganem, G, LeRol, A, Antoine, EC, Llory, JF, Loiseau, D

Get full text

6 months versus 12 months of adjuvant trastuzumab for patients with HER2-positive early breast cancer (PHARE): a randomised phase 3 trial by Pivot, Xavier, Prof, Romieu, Gilles, MD, Debled, Marc, MD, Pierga, Jean-Yves, Prof, Kerbrat, Pierre, Prof, Bachelot, Thomas, MD, Lortholary, Alain, MD, Espié, Marc, MD, Fumoleau, Pierre, Prof, Serin, Daniel, MD, Jacquin, Jean-Philippe, MD, Jouannaud, Christelle, MD, Rios, Maria, MD, Abadie-Lacourtoisie, Sophie, MD, Tubiana-Mathieu, Nicole, Prof, Cany, Laurent, MD, Catala, Stéphanie, MD, Khayat, David, Prof, Pauporté, Iris, PhD, Kramar, Andrew, PhD

Get full text

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei of appendicular and extra‐appendicular origin by Delhorme, J.‐B., Severac, F., Averous, G., Passot, G., Bakrin, N., Marchal, F., Pocard, M., Lo Dico, R., Eveno, C., Carrere, S., Sgarbura, O., Quenet, F., Ferron, G., Goéré, D., Brigand, C., Abba, J., Abboud, K., Alyami, M., Arvieux, C., Averous, G., Balagué, G., Barrau, V., Bereder, J.‐M., Berton‐Rigaud, I., Bibeau, F., Bonnefoy, I., Bouzard, D., Bricault, I., Brigand, C., Carrère, S., de Chaisemartin, C., Chassang, M., Chevallier, A., Courvoisier, T., Dohan, A., Dubreuil, J., Dumont, F., Eveno, C., Faruch‐Bilfeld, M., Fontaine, J., Fournier, L., Gagniere, J., Geffroy, D., Ghouti, L., Gilly, F.‐N., Gladieff, L., Glehen, O., Guibal, A., Guilloit, J.‐M., Guyon, F., Heyd, B., Hoeffel, C., Hordonneau, C., Isaac, S., Jourdan‐Enfer, P., Kianmanesh, R., Labbé‐Devilliers, C., Lacroix, J., Lelong, B., Leroux‐Broussier, A., Lherm, Y., Lo Dico, R., Lorimier, G., Malhaire, C., Marchal, F., Mariani, P., Mathiotte, E., Meeus, P., Mery, E., Msika, S., Nadeau, C., Passot, G., Pellet, O., Peyrat, P., Pezet, D., Pirro, N., Poizat, F., Porcheron, J., Poulet, A., Quenet, F., Rat, P., Rousselot, P., Rousset, P., Senellart, H., Serrano, M., Servois, V., Sgabura, O., Skanjeti, A., Svrcek, M., Tetreau, R., Thibaudeau, E., Touchefeu, Y., Tuech, J.‐J., Valmary‐Degano, S., Vaudoyer, D., Velasco, S., Verriele‐Beurrier, V., Villeneuve, L., Wernert, R., Zinzindohoue, F.

Get full text

Well-Differentiated Papillary Mesothelioma of the Peritoneum: A Retrospective Study from the RENAPE Observational Registry by Vogin, Guillaume, Hettal, Liza, Vignaud, Jean-Michel, Dartigues, Peggy, Goere, Diane, Ferron, Gwenaël, Heyd, Bruno, Bereder, Jean-Marc, Tuech, Jean-Jacques, Glehen, Olivier, de Chaisemartin, Cécile, Lherm, Yoann, Villeneuve, Laurent, Kepenekian, Vahan, Marchal, Frédéric

Get full text

Recurrence of pseudomyxoma peritonei after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy by Mercier, F., Dagbert, F., Pocard, M., Goéré, D., Quenet, F., Wernert, R., Dumont, F., Brigand, C., Passot, G., Glehen, O., Abba, J., Abboud, K., Alyami, M., Arvieux, C., Averous, G., Bakrin, N., Balagué, G., Barrau, V., Ben Rejeb, H., Bereder, J. M., Berton Rigaud, I., Bibeau, F., Bonnefoy, I., Bouzard, D., Bricault, I., Caramella, C., Carrère, S., Chaisemartin, C., Chassang, M., Chevallier, A., Courvoisier, T., Dartigues, P., Dohan, A., Eveno, C., Faruch Bilfeld, M., Ferron, G., Fontaine, J., Fournier, L., Gabiache, E., Gagniere, J., Geffroy, D., Ghouti, L., Gilly, F. N., Gladieff, L., Guibal, A., Guilloit, J. M., Guyon, F., Heyd, B., Hoeffel, C., Hordonneau, C., Isaac, S., Jourdan Enfer, P., Kaci, R., Kianmanesh, R., Labbé Devilliers, C., Lacroix, J., Lelong, B., Leroux Broussier, A., Lherm, Y., Lo Dico, R., Lorimier, G., Malhaire, C., Marchal, F., Mariani, P., Mathiotte, E., Meeus, P., Mery, E., Msika, S., Nadeau, C., Nougaret, S., Ortega Deballon, P., Paquette, B., Pellet, O., Peyrat, P., Pezet, D., Pirro, N., Pocard, M., Poizat, F., Porcheron, J., Rat, P., Rousselot, P., Rousset, P., Senellart, H., Serrano, M., Servois, V., Sgarbura, O., Skanjeti, A., Svrcek, M., Tetreau, R., Thibaudeau, E., Touchefeu, Y., Tuech, J. J., Valmary Degano, S., Vaudoyer, D., Velasco, S., Verriele Beurrier, V., Villeneuve, L., Zinzindohoue, F.

Get full text

Immunohistochemical evaluation of two antibodies against PD-L1 and prognostic significance of PD-L1 expression in epithelioid peritoneal malignant mesothelioma: a RENAPE study by Valmary-Degano, Séverine, Colpart, Prudence, Villeneuve, Laurent, Monnien, Franck, M’Hamdi, Loubna, Lang-Averous, Gerlinde, Capovilla, Mathieu, Bibeau, Frederic, Laverriere, Marie-Hélène, Verriele-Beurrier, Véronique, Ben Rejeb, Houda, Dartigues, Peggy, Hommell-Fontaine, Juliette, Gilly, François-Noël, Isaac, Sylvie, Mery, Eliane

Get full text

Epidermal Growth Factor Receptor (EGFR) Pathway Biomarkers in the Randomized Phase III Trial of Erlotinib Versus Observation in Ovarian Cancer Patients with No Evidence of Disease... by Despierre, Evelyn, Vergote, Ignace, Anderson, Ryan, Coens, Corneel, Katsaros, Dionyssios, Hirsch, Fred R., Boeckx, Bram, Varella-Garcia, Marileila, Ferrero, Annamaria, Ray-Coquard, Isabelle, Berns, Els M. J. J., Casado, Antonio, Lambrechts, Diether, Jimeno, Antonio

Get full text

Management of rare ovarian cancers: The experience of the French website «Observatory for rare malignant tumours of the ovaries» by the GINECO group: Interim analysis of the first... by Ray-Coquard, Isabelle, Weber, Béatrice, Lotz, Jean Pierre, Tournigand, Christophe, Provencal, Jocelyne, Mayeur, Didier, Treilleux, Isabelle, Paraiso, Désiré, Duvillard, Pierre, Pujade-Lauraine, Éric

Get full text

Hormonoresistance in advanced breast cancer: a new revolution in endocrine therapy by Augereau, Paule, Patsouris, Anne, Bourbouloux, Emmanuelle, Gourmelon, Carole, Abadie Lacourtoisie, Sophie, Berton Rigaud, Dominique, Soulié, Patrick, Frenel, Jean Sebastien, Campone, Mario

Get full text

Long-term safety in patients with recurrent ovarian cancer treated with niraparib versus placebo: Results from the phase III ENGOT-OV16/NOVA trial by Mirza, Mansoor R., Benigno, B., Dørum, A., Mahner, S., Bessette, P., Barceló, I. Bover, Berton-Rigaud, D., Ledermann, J.A., Rimel, B.J., Herrstedt, J., Lau, S., du Bois, A., Herráez, A. Casado, Kalbacher, E., Buscema, J., Lorusso, D., Vergote, I., Levy, T., Wang, P., de Jong, F.A., Gupta, D., Matulonis, U.A.

Get full text

Validation of the modified Glasgow Prognostic Score (mGPS) in recurrent ovarian cancer (ROC) – Analysis of patients enrolled in the GCIG Symptom Benefit Study (SBS) by Roncolato, Felicia T., Berton-Rigaud, Dominique, O'Connell, Rachel, Lanceley, Anne, Sehouli, Jalid, Buizen, Luke, Okamoto, Aikou, Aotani, Eriko, Lorusso, Domenica, Donnellan, Paul, Oza, Amit, Avall-Lundqvist, Elisabeth, Berek, Jonathan, Hilpert, Felix, Ledermann, Jonathan A., Kaminsky, Marie Christine, Stockler, Martin R., King, Madeleine T., Friedlander, Michael

Get full text

Phase II study of the PI3K inhibitor BKM120 in patients with advanced or recurrent endometrial carcinoma: a stratified type I–type II study from the GINECO group by Heudel, P-E, Fabbro, M, Roemer-Becuwe, C, Kaminsky, M C, Arnaud, A, Joly, F, Roche-Forestier, S, Meunier, J, Foa, C, You, B, Priou, F, Tazi, Y, Floquet, A, Selle, F, Berton-Rigaud, D, Lesoin, A, Kalbacher, E, Lortholary, A, Favier, L, Treilleux, I, Ray-Coquard, I

Get full text

Reducing Uncertainty: Predictors of Stopping Chemotherapy Early and Shortened Survival Time in Platinum Resistant/Refractory Ovarian Cancer—The GCIG Symptom Benefit Study by Roncolato, Felicia T., Joly, Florence, O'Connell, Rachel, Lanceley, Anne, Hilpert, Felix, Buizen, Luke, Okamoto, Aikou, Aotani, Eriko, Pignata, Sandro, Donnellan, Paul, Oza, Amit, Avall‐Lundqvist, Elisabeth, Berek, Jonathan S., Heitz, Florian, Feeney, Amanda, Berton‐Rigaud, Dominique, Stockler, Martin R., King, Madeleine, Friedlander, Michael

Get full text

Menopausal symptoms in epithelial ovarian cancer survivors: a GINECO VIVROVAIRE2 study by Gernier, F., Gompel, A., Rousset-Jablonski, C., Kalbacher, E., Floquet, A., Berton-Rigaud, D., Tredan, O., Alexandre, J., Follana, P., Zannetti, A., Dohollou, N., Grellard, J.-M., Clarisse, B., Licaj, I., Ahmed-Lecheheb, D., Fauvet, R., Pautier, P., Joly, F.

Get full text

The CD47/TSP-1 axis: a promising avenue for ovarian cancer treatment and biomarker research by Moniot, Aurélie, Schneider, Christophe, Chardin, Laure, Yaniz-Galende, Elisa, Genestie, Catherine, Etiennot, Marion, Henry, Aubéri, Drelon, Coralie, Le Formal, Audrey, Langlois, Benoit, Venat, Laurence, Louvet, Christophe, Favier, Laure, Lortholary, Alain, Berton-Rigaud, Dominique, Dohollou, Nadine, Desauw, Christophe, Fabbro, Michel, Malaurie, Emmanuelle, Dubot, Coraline, Kurtz, Jean Emmanuel, Bonichon Lamichhane, Nathalie, Pujade-Lauraine, Éric, Jeanne, Albin, Leary, Alexandra, Dedieu, Stéphane

Get full text

Need for risk-adapted therapy for malignant ovarian germ cell tumors: A large multicenter analysis of germ cell tumors' patients from French TMRG network by Derquin, F., Floquet, A., Hardy-Bessard, A.C., Edeline, J., Lotz, J.P., Alexandre, J., Pautier, P., Angeles, M.A., Delanoy, N., Lefeuvre-Plesse, C., Cancel, M., Treilleux, I., Augereau, P., Lavoue, V., Kalbacher, E., Berton Rigaud, D., Selle, F., Nadeau, C., Gantzer, J., Joly, F., Guillemet, C., Pomel, C., Favier, L., Abdeddaim, C., Venat-Bouvet, L., Provansal, M., Fabbro, M., Kaminsky, M.C., Lortholary, A., Lecuru, F., Coquard, I. Ray, de La Motte Rouge, T.

Get full text

Measuring what matters MOST: validation of the Measure of Ovarian Symptoms and Treatment, a patient-reported outcome measure of symptom burden and impact of chemotherapy in recurre... by King, Madeleine T., Stockler, Martin R., O'Connell, Rachel L., Buizen, Luke, Joly, Florence, Lanceley, Anne, Hilpert, Felix, Okamoto, Aikou, Aotani, Eriko, Bryce, Jane, Donnellan, Paul, Oza, Amit, Avall-Lundqvist, Elisabeth, Berek, Jonathan S., Sehouli, Jalid, Feeney, Amanda, Berton-Rigaud, Dominique, Costa, Daniel S. J., Friedlander, Michael L.

Get full text